Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allicin Pretreatment for Delayed Onset Muscle Soreness
NCT07812688Completed
- Sponsor
- Guangxi Normal University
- Start
- Apr 2024
- Primary completion
- Jun 2024
- Countries
- 1
01
Overview
Randomised, double-blind trial in delayed onset muscle soreness (DOMS) comparing allicin group with placebo group (2 arms). Primary endpoint: Subjective Pain Sensation. Started Apr 2024; status: completed.
02
Drugs
allicin
03
Conditions
delayed onset muscle soreness (DOMS)
Beyond the preview
Go deeper on NCT07812688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07812688.